Humacyte, Inc. (HUMA) Misses Q1 EPS by 15c

Humacyte, Inc. (NASDAQ: HUMA) reported Q1 EPS of ($0.36), $0.15 worse than the analyst estimate of ($0.21).

For earnings history and earnings-related data on Humacyte, Inc. (HUMA) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Genco rejects Diana Shipping takeover bid as undervalued
• Rothschild Redburn Upgrades Apple (AAPL) to Buy